Literature DB >> 34533588

Different Risk Factors for Early and Late Recurrence After Curative Resection of Hepatocellular Carcinoma.

Suk Kyun Hong1, Xue-Li Jin1,2, Sanggyun Suh1, Su Young Hong1, Kwangpyo Hong1, Eui Soo Han1, Jeong-Moo Lee1, YoungRok Choi1, Nam-Joon Yi1, Kwang-Woong Lee1, Kyung-Suk Suh3.   

Abstract

BACKGROUND: Factors of early and late recurrence after curative resection of hepatocellular carcinoma (HCC) may be different. The aim of this study was to identify clinical factors, including liver stiffness measurement (LSM), which are associated with HCC recurrence after curative resection.
METHODS: Patients who underwent preoperative LSM and primary curative resection for HCC between October 2015 and May 2018 were retrospectively reviewed, with 1 year as the cut-off between early and late recurrence.
RESULTS: Recurrence was observed in 42/149 (28.2%) patients over a median follow-up of 38.3 months (early recurrence: 10 [6.7%] patients; late recurrence: 32 [21.5%] patients). Multivariate analysis identified LSM (P = 0.026) and tumor size (P = 0.010) as the only factors that were significantly associated with recurrence-free survival. Compared with patients without recurrence, those with early recurrence had larger tumor size (P = 0.035) and those with late recurrence had higher LSM (P = 0.024). Receiver-operating characteristic analysis indicated that the optimal LSM cut-off value for predicting HCC recurrence was 7.4 kPa.
CONCLUSION: Tumor size was associated with early HCC recurrence after curative resection and LSM was associated with late recurrence. LSM cut-off of 7.4 kPa is recommended in predicting recurrence.
© 2021. Société Internationale de Chirurgie.

Entities:  

Mesh:

Year:  2021        PMID: 34533588     DOI: 10.1007/s00268-021-06308-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  44 in total

Review 1.  Hepatitis B virus-induced oncogenesis.

Authors:  Joachim Lupberger; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Is Disruptive Behavior Inherent to the Surgeon or the Environment? Analysis of 314 Events at a Single Academic Medical Center.

Authors:  Martin J Heslin; Brandon A Singletary; Kaitlin C Benos; Laura Read Lee; Charles Fry; Brenessa Lindeman
Journal:  Ann Surg       Date:  2019-09       Impact factor: 12.969

3.  Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma.

Authors:  T J Tsai; G Y Chau; W Y Lui; S H Tsay; K L King; C C Loong; C Y Hsia; C W Wu
Journal:  Surgery       Date:  2000-06       Impact factor: 3.982

4.  Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration.

Authors:  Ji-An Chen; Ming Shi; Jin-Qing Li; Chao-Nan Qian
Journal:  Hepatol Int       Date:  2010-07-29       Impact factor: 6.047

Review 5.  Diagnosis and treatment of hepatocellular carcinoma.

Authors:  Hashem B El-Serag; Jorge A Marrero; Lenhard Rudolph; K Rajender Reddy
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

6.  Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma.

Authors:  Y Sasaki; S Imaoka; S Masutani; I Ohashi; O Ishikawa; H Koyama; T Iwanaga
Journal:  Surgery       Date:  1992-09       Impact factor: 3.982

Review 7.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

Authors:  Jordi Bruix; Maria Reig; Morris Sherman
Journal:  Gastroenterology       Date:  2016-01-12       Impact factor: 22.682

8.  Predictive factors of microvascular invasion in patients with hepatocellular carcinoma larger than 5 cm.

Authors:  Yasuhiko Nagano; Hiroshi Shimada; Kazuhisa Takeda; Michio Ueda; Kenichi Matsuo; Kuniya Tanaka; Itaru Endo; Chikara Kunisaki; Shinji Togo
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

9.  Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.

Authors:  Shuji Sumie; Ryoko Kuromatsu; Koji Okuda; Eiji Ando; Akio Takata; Nobuyoshi Fukushima; Yasutomo Watanabe; Masamichi Kojiro; Michio Sata
Journal:  Ann Surg Oncol       Date:  2008-03-07       Impact factor: 5.344

10.  Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

Authors:  Charles Cha; Yuman Fong; William R Jarnagin; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2003-11       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.